Degenerative processes or vascular disorder can, in the beginning, present a clinical picture very similar to idiopathic Parkinsonism but, in most cases, the diagnosis is not made different by the absence of a biological test for this disease. However, a biological marker could be very useful for studying the evolution of the disease, and for understanding fluctua- likely that a more general and more neurotoxic process than that resulting from the binding on specific dopamine receptors could be partially involved.
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